Illicit cocaine and methamphetamine containing opioids
Following ongoing identification of cases of opioid overdose after use of substances expected to be cocaine or methamphetamine in NSW, a Safety Notice for Clinicians (012/26) has been published on the NSW Health website. The Safety Notice will also be distributed via the Clinical Excellence Commission’s Safety Alert Broadcast System.
Additionally, one person has died and multiple people in four separate incidents across Victoria have required emergency care because they experienced heroin overdose after using what they thought was cocaine or methamphetamine. Specialised blood tests showed evidence of heroin as well as cocaine and methamphetamine, suggesting that heroin may have been mixed into these drugs (‘adulteration’).
Please see the drug alert issued by the Victorian Department of Health.
Please share this information with your patients, peers, clients, and professional networks as appropriate.
Know the signs of opioid overdose and access naloxone
Signs of opioid overdose include breathing slowly and reduced consciousness (meaning someone is hard to wake up). In some cases, the person may also have tiny pupils. More information about opioid overdose symptoms can be found on the Penington Institute website.
Naloxone is a life-saving medicine that can temporarily reverse an opioid overdose. Naloxone is available in an easy to use nasal spray, and as a pre-filled injection.
HealthPathways is getting a refreshed look From 17 September 2026, HealthPathways Sydney and South Eastern Sydney sites will launch a refreshed layout designed to provide a clearer and more user-friendly experience. New features: Simplified homepage More prominent search bar Improved toolbar for common actions – including CPD notes and expand/collapse…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Protecting Adolescents Against Human Papillomavirus: The Pivotal Role of Primary Care Fluad vaccine stock exhausted COVID-19 vaccine NIP transition Education Protecting Adolescents Against Human Papillomavirus: The Pivotal Role of Primary Care Twenty years after the…
GP Liaison in Alcohol and Other Drugs (GLAD) service support for general practice Evidence shows that people living with significant alcohol or drug related harm often delay seeking care and minimise their healthcare needs. They may live with chronic or complex illnesses with adverse health impacts routinely seen in much older patients. As a result, when assessing…
Immunisation Weekly Update: Diphtheria: NSW Vaccination Recommendations NSW Health childhood vaccination campaign toolkit New respiratory syncytial virus (RSV) maternal vaccination resource Education Diphtheria: NSW Vaccination Recommendations NSW Health is reminding providers to check the diphtheria vaccination status of all Aboriginal people and offer vaccination where eligible. A NSW-funded vaccination program is currently available…
Immunisation Weekly Update: Promote Japanese Encephalitis Vaccination Ahead of Travel Measles Immunity Gaps: A Timely Reminder to Check Vaccine Status COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar Education Promote Japanese Encephalitis Vaccination Ahead of Travel Funded JE vaccination is available for eligible…
Immunisation Weekly Update: Capvaxive stock exhausted Current stocks of Capvaxive have been exhausted due to ongoing supply and distribution constraints, resulting in a temporary vaccine shortage. Further stock is anticipated to arrive in the coming weeks. Please ensure clinics or appointments for eligible patients are only booked when you have…